Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
8.77
+0.44 (5.28%)
At close: May 12, 2025, 4:00 PM
8.75
-0.02 (-0.23%)
After-hours: May 12, 2025, 6:32 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $624.17 million as of May 12, 2025. Its market cap has decreased by -46.31% in one year.
Market Cap
624.17M
Enterprise Value
103.99M
1-Year Change
-46.31%
Ranking
Category
Stock Price
$8.77
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $624.17M, an increase of 154.35%. That is a compound annual growth rate of 8.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 592.90M | -63.13% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |